Study on the antigens and antibodies of Mur and Mia blood groups in southern China

Published:January 31, 2022DOI:



      The frequency of Mur and Mia blood group antigens in Asian population is much higher than that in Caucasian population. However, due to the scarcity and high price of commercial detection reagents, there are few studies on antigen and antibody detection and comparative analysis in large samples.


      To study the occurrence frequency, antigen correlation and antibody properties of Mur and Mia antigens and their corresponding antibodies in southern China.


      Mur and Mia antigens and antibodies in local blood donors and patients were detected by routine serological microplate method. Statistical methods were used to calculate the incidence of two antigens and antibodies and analyze their correlation.


      Among blood donors, the positive rates of Mur and Mia antigens were 6.4 % and 6.5 % respectively, with no significant difference (P > 0.05). In this region, the incidence of anti-"Mur" and anti-"Mia" was 0.65 % and 0.45 % respectively. But significant difference existed between blood donors and patients (P < 0.05). Among the anti-"Mur" and anti-"Mia" positive patients, most of the antibodies were IgM or IgM + IgG mixed type and had saline activity.


      Mur and Mia antigens and their corresponding antibodies have a high frequency in the population of southern China. In the routine clinical detection of irregular antibodies, Mur or Mia positive (GP.Mur) should be added to screen erythrocytes. Moreover, given the high correlation between Mur and Mia antigens expression on red blood cells, using monoclonal antibodies against Mia could predict the presence of Mur antigen.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Wei S.S.
        • Sun A.N.
        • Ding S.H.
        • et al.
        Mur (MNS 10) screening with a novel loop-mediated isothermal amplification assay in Zhongshan China.
        Transfus Med. 2016; 26: 215-219
        • Daniels G.
        Human blood groups.
        3rd ed. Oxford,Wiley-Blackwell, UK2013: 96-161
        • Broadberry R.E.
        • Lin M.
        The incidence and significance of anti-"Mia" in Taiwan.
        Transfusion. 1994; 34: 349-352
        • Mallari R.A.
        • Chan A.
        • Powers R.J.
        • et al.
        Fetal inheritance of GP*Mur causing severe HDFN in an unrecognized case of maternal alloimmunization.
        Transfusion. 2020; 60: 870-874
        • Lin C.K.
        • Mak K.H.
        • Szeto S.C.
        • et al.
        First case of haemolytic disease of the newborn due to anti-Mur in Hong Kong.
        Clin Lab Heamatol. 1996; 18: 19-22
        • Bakhtary S.
        • Gikas A.
        • Glader B.
        • et al.
        Anti-Mur as the most likely cause of mild hemolytic disease of the newborn.
        Transfusion. 2016; 56: 1182-1184
        • Molthan L.
        Intravascular hemolytic transfusion reaction due to anti-Vw+ Mia with fatal outcome.
        Vox Sang. 1981; 40: 105-108
        • Wu K.H.
        • Chang J.G.
        • Lin M.
        • et al.
        Hydrops foetalis caused by anti-Mur in first pregnancy - a case report.
        Transfus Med. 2002; 12: 325-327
        • Li S.
        • Wei L.
        • Fang Q.
        • et al.
        Successful prenatal management of two foetuses affected by antibodies against GP.Mur with prenatal genotyping analysis and a literature review.
        Blood Transfusion. 2021; 19: 135-143
        • Sun A.N.
        • Wei S.S.
        • Liao Y.T.
        • et al.
        Identification and application of human Mur blood group antibody (affiliates one case report).
        Chin J Blood Transfusion. 2016; 29: 1327-1330
        • Li Q.
        • Sun A.N.
        • Duan S.B.
        • et al.
        Prevalence of anti-“Mia” in blood donors and patients, Zhongshan city.
        Chin J Blood Transfusion. 2021; 34: 114-117
        • Fung M.K.
        • Grossman B.J.
        • Hillyer C.D.
        • et al.
        AABB technical manual.
        18th edn. AABB Press, Bethesda2014 (138,METHOD 2-2, METHOD 2-3)
        • Sun A.N.
        • Li Q.
        • Xiang D.
        • et al.
        Chinese Mia and Mur blood type research and the first discovery of GP.VW.
        Chin J Blood Transfusion. 2018; 31: 943-947
        • Wei L.
        • Sun A.N.
        • Wen J.Z.
        • et al.
        Molecular genetic analysis of Mia-positive hybrid glycophorins revealed two novel alleles of GP.VW and multiple variant transcripts of GYPB existing in both the homozygous GP.MUr and wild-type GPB individuals.
        Transfusion. 2021;
        • Wei L.
        • Shan Z.G.
        • Flower R.L.
        • et al.
        The distribution of MNS hybrid glycophorins with Mur antigen expression in Chinese donors including identification of a novel GYP.BUn allele.
        Vox Sang. 2016; 111: 308-314
        • Poole J.
        • King M.J.
        • Mak K.H.
        • et al.
        The MiIII phenotype among Chinese donors in Hong Kong: immunochemical and serological studies.
        Transfus Med. 1991; 1: 169-175
        • Zhu Z.Y.
        • Shen W.
        • Chen H.P.
        • et al.
        Rare blood group screening among Chinese blood donors in Shanghai area.
        Chin J Blood Transfusion. 2002; 15: 232-233
        • Zhou J.
        • Lv R.
        • Zhou B.Q.
        • et al.
        Detection of Miltenberger hybrid glycophorins of MNS system in the Chinese Han population.
        Acta Universitatis Medicinalis Anhui. 2014; 49: 313-315
        • Broadberry R.E.
        • Lin M.
        The distribution of the MiIII (GP.Mur) phenotype among the population of Taiwan.
        Transfus Med. 1996; 6: 145-148
        • Lopez G.H.
        • Wilson B.
        • Turner R.M.
        • et al.
        Frequency of Mia (MNS7) and classification of mia-positive hybrid glycophorins in an australian blood donor population.
        Transfus Med Hemother. 2020; 47: 279-286
        • Lin X.
        • Rubio G.
        • Patel J.
        • et al.
        Hybrid glycophorin and red blood cell antigen genotyping in Asian American type O blood donors with Mia phenotype.
        Transfusion. 2019; 59: 3767-3775
        • Mo Z.
        • Li H.
        • Huang L.
        • et al.
        Prevalence and specificity of RBC alloantibodies in the general hospitalised population in Guangxi.
        Transfus Med. 2015; 25: 313-319
        • Prathiba R.
        • Lopez C.G.
        • Usin F.M.
        The prevalence of GP.MUr and anti-"Mia" in a tertiary hospital in Peninsula Malaysia.
        Malays J Pathol. 2002; 24: 95-98
        • Chen C.X.
        • Tan J.Z.
        • Wang L.X.
        • et al.
        Unexpected red blood cell antibody distributions in Chinese people by a systematic literature review.
        Transfusion. 2016; 56: 975-979